Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting

Journal of Bone and Mineral Research

Volumn 26, Issue 12, 2011, Pages 2923-2934

  Alonso, Verõnica ^a   Magyar, Clara E ^a   Wang, Bin ^a   Bisello, Alessandro ^a   Friedman, Peter A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

DEUBIQUITINASE ENZYMES; PTH RECEPTOR; RECEPTOR DOWNREGULATION; RECEPTOR RECYCLING; UBIQUITINATION

Indexed keywords

PARATHYROID HORMONE; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE[1-34]; PARATHYROID HORMONE[7-34]; PARATHYROID HORMONE[7-84]; PROTEASOME; PROTEINASE; UBIQUITIN SPECIFIC PROTEASE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEUBIQUITINATION; DOWN REGULATION; ENDOCYTOSIS; GENE OVEREXPRESSION; LIGAND BINDING; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; CELL MEMBRANE; DOWN-REGULATION; ENDOCYTOSIS; ENDOPEPTIDASES; GENE SILENCING; HUMANS; LIGANDS; MICE; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN TRANSPORT; PROTEOLYSIS; RATS; RECEPTORS, PARATHYROID HORMONE; UBIQUITINATION;

EID: 81855193741     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.494     Document Type: Article

References (70)

1. Ferguson SS,. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev. 2001; 53: 1-24. (Pubitemid 32173106)
2. Wolfe BL, Trejo J,. Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis. Traffic. 2007; 8: 462-70. (Pubitemid 46638559)
3. Malecz N, Bambino T, Bencsik M, Nissenson RA,. Identification of phosphorylation sites in the G protein-coupled receptor for parathyroid hormone. Receptor phosphorylation is not required for agonist-induced internalization. Mol Endocrinol. 1998; 12: 1846-56. (Pubitemid 28544180)
4. Chauvin S, Bencsik M, Bambino T, Nissenson RA,. PTH receptor recycling: role of receptor dephosphorylation and ß-arrestin. Mol Endocrinol. 2002; 16: 2720-32. (Pubitemid 36020653)
5. Tawfeek HA, Qian F, Abou-Samra AB,. Phosphorylation of the receptor for PTH and PTHrP is required for internalization and regulates receptor signaling. Mol Endocrinol. 2002; 16: 1-13. (Pubitemid 34044493)
6. Vilardaga JP, Krasel C, Chauvin S, Bambino T, Lohse MJ, Nissenson RA,. Internalization determinants of the parathyroid hormone receptor differentially regulate ß-arrestin/receptor association. J Biol Chem. 2002; 277: 8121-9. (Pubitemid 34968266)
7. Miedlich SU, Abou-Samra AB,. Eliminating phosphorylation sites of the parathyroid hormone receptor type 1 differentially affects stimulation of phospholipase C and receptor internalization. Am J Physiol Endocrinol Metab. 2008; 295: E665-71.
8. Ferrari SL, Behar V, Chorev M, Rosenblatt M, Bisello A,. Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is PKC-dependent and involves ß-arrestin2. Real-time monitoring by fluorescence microscopy. J Biol Chem. 1999; 274: 29968-75.
9. Conway BR, Minor LK, Xu JZ, D'Andrea MR, Ghosh RN, Demarest KT,. Quantitative analysis of agonist-dependent parathyroid hormone receptor trafficking in whole cells using a functional green fluorescent protein conjugate. J Cell Physiol. 2001; 189: 341-55. (Pubitemid 33063302)
10. Sneddon WB, Syme CA, Bisello A, Magyar CE, Weinman EJ, Rochdi MD, Parent JL, Abou-Samra AB, Friedman PA,. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J Biol Chem. 2003; 278: 43787-96. (Pubitemid 37346007)
11. Wheeler DG, Sneddon WB, Wang B, Friedman PA, Romero G,. NHERF-1 and the cytoskeleton regulate the traffic and membrane dynamics of G protein-coupled receptors. J Biol Chem. 2007; 282: 25076-87. (Pubitemid 47347543)
12. Wang B, Yang Y, Abou-Samra AB, Friedman PA,. NHERF1 regulates parathyroid hormone receptor desensitization; interference with ß-arrestin binding. Mol Pharmacol. 2009; 75: 1189-97.
13. Tamura T, Sakamoto H, Filburn CR,. Parathyroid hormone 1-34, but not 3-34 or 7-34, transiently translocates PKC in cultured renal (OK) cells. Biochem Biophys Res Commun. 1989; 159: 1352-8. (Pubitemid 19101131)
14. Fujimori A, Cheng S-L, Avioli LV, Civitelli R,. Structure-function relationship of parathyroid hormone: activation of phospholipase-C, protein kinase-A and -C in osteosarcoma cells. Endocrinology. 1992; 130: 29-36.
15. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A,. A novel mechanism for skeletal resistance in uremia. Kidney Int. 2000; 58: 753-61. (Pubitemid 30620025)
16. Gentili C, Boland R, de Boland AR,. PTH stimulates PLCβ and PLCγ isoenzymes in rat enterocytes: influence of ageing. Cell Signal. 2001; 13: 131-8. (Pubitemid 32222983)
17. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, D'Amour P,. A non-(I-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem. 1998; 44: 805-9. (Pubitemid 28176023)
18. John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Jüppner H,. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure. J Clin Endocrinol Metab. 1999; 84: 4287-90. (Pubitemid 30644232)
19. Coen G, Bonucci E, Ballanti P, Balducci A, Calabria S, Nicolai GA, Fischer MS, Lifrieri F, Manni M, Morosetti M, Moscaritolo E, Sardella D,. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis. 2002; 40: 348-54. (Pubitemid 34827653)
20. Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH,. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int. 2001; 60: 1460-8. (Pubitemid 32960040)
21. Yamashita H, Gao P, Cantor T, Futata T, Murakami T, Uchino S, Watanabe S, Kawamoto H, Fukagawa M, Noguchi S,. Large carboxy-terminal parathyroid hormone (PTH) fragment with a relatively longer half-life than 1-84 PTH is secreted directly from the parathyroid gland in humans. Eur J Endocrinol. 2003; 149: 301-6. (Pubitemid 37304700)
22. Ureña P, Kubrusly M, Mannstadt M, Hruby M, Trinh Trang Tan M-M, Silve C, Lacour B, Abou-Samra AB, Segre GV, Drüeke T,. The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int. 1994; 45: 605-11. (Pubitemid 24065100)
23. Tian J, Smogorzewski M, Kedes L, Massry SG,. PTH-PTHrP receptor mRNA is downregulated in chronic renal failure. Am J Nephrol. 1994; 14: 41-6. (Pubitemid 24121291)
24. Edwards RM, Contino LC, Gellai M, Brooks DP,. Parathyroid hormone-1 receptor down-regulation in kidneys from rats with chronic renal failure. Pharmacology. 2001; 62: 243-7. (Pubitemid 32453764)
25. Chen J, Zhang J, Lin S,. Down-regulation of PTH/PTHrP receptor in the kidney of patients with renal impairment. Chin Med J (Engl). 1998; 111: 24-7. (Pubitemid 128515222)
26. Shenoy SK,. Seven-transmembrane receptors and ubiquitination. Circ Res. 2007; 100: 1142-54. (Pubitemid 46684127)
27. Wojcikiewicz RJ,. Regulated ubiquitination of proteins in GPCR-initiated signaling pathways. Trends Pharmacol Sci. 2004; 25: 35-41. (Pubitemid 38076955)
28. Hurley JH, Stenmark H,. Molecular mechanisms of ubiquitin-dependent membrane traffic. Annu Rev Biophys. 2010.
29. Cook LB, Zhu C-C, Hinkle PM,. Thyrotropin-releasing hormone receptor processing: role of ubiquitination and proteasomal degradation. Mol Endocrinol. 2003; 17: 1777-91. (Pubitemid 37072294)
30. Cohen BD, Bariteau JT, Magenis LM, Dias JA,. Regulation of follitropin receptor cell surface residency by the ubiquitin-proteasome Pathway. Endocrinology. 2003; 144: 4393-402. (Pubitemid 37204838)
31. Martin NP, Lefkowitz RJ, Shenoy SK,. Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination. J Biol Chem. 2003; 278: 45954-9. (Pubitemid 37432742)
32. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ,. Regulation of receptor fate by ubiquitination of activated ß2-adrenergic receptor and ß-Arrestin. Science. 2001; 294: 1307-13. (Pubitemid 33063090)
33. Lupp A, Klenk C, Rocken C, Evert M, Mawrin C, Schulz S,. Immunohistochemical identification of the PTHR1 parathyroid hormone receptor in normal and neoplastic human tissues. Eur J Endocrinol. 2010; 162: 979-86.
34. Wang B, Bisello A, Yang Y, Romero GG, Friedman PA,. NHERF1 regulates parathyroid hormone receptor membrane retention without affecting recycling. J Biol Chem. 2007; 282: 36214-22.
35. Zhang P, Jobert AS, Couvineau A, Silve C,. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J Clin Endocrinol Metab. 1998; 83: 3365-8. (Pubitemid 28500987)
36. Wang B, Yang Y, Friedman PA,. Na/H Exchange regulator factor 1, a novel Akt-associating protein, regulates extracellular signal-related signaling through a B-Raf-mediated pathway. Mol Biol Cell. 2008; 19: 1637-45. (Pubitemid 351805116)
37. Wang B, Yang Y,. Generation of human PTH1R construct with Flag epitope located internally: comparison of two-fragment assembly by using PCR overlap extension or ligase. J Biomol Tech. 2009; 20: 195-200.
38. Alonso V, Ardura JA, Wang B, Sneddon WB, Friedman PA,. A naturally occurring isoform inhibits parathyroid hormone receptor trafficking and signaling. J Bone Miner Res. 2011; 26: 143-55.
39. Chaturvedi K, Bandari P, Chinen N, Howells RD,. Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors. J Biol Chem. 2001; 276: 12345-55.
40. Lee DH, Goldberg AL,. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998; 8: 397-403. (Pubitemid 28458705)
41. Salcini AE, Chen H, Iannolo G, De Camilli P, Di Fiore PP,. Epidermal growth factor pathway substrate 15, Eps15. Int J Biochem. 1999; 31: 805-9. (Pubitemid 29354077)
42. de Melker AA, van der Horst G, Borst J,. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment. J Biol Chem. 2004; 279: 55465-73. (Pubitemid 40066547)
43. Kuhlbrodt K, Mouysset J, Hoppe T,. Orchestra for assembly and fate of polyubiquitin chains. Essays Biochem. 2005; 41: 1-14. (Pubitemid 41500967)
44. Reyes-Turcu FE, Ventii KH, Wilkinson KD,. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem. 2009; 78: 363-97.
45. Miles RR, Sluka JP, Halladay DL, Santerre RF, Hale LV, Bloem L, Patanjali SR, Galvin RJ, Ma L, Hock JM, Onyia JE,. Parathyroid hormone (hPTH 1-38) stimulates the expression of UBP41, an ubiquitin-specific protease, in bone. J Cell Biochem. 2002; 85: 229-42. (Pubitemid 34274891)
46. Willins DL, Berry SA, Alsayegh L, Backstrom JR, Sanders-Bush E, Friedman L, Roth BL,. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Neuroscience. 1999; 91: 599-606. (Pubitemid 29193269)
47. Bhowmick N, Narayan P, Puett D,. The endothelin subtype A receptor undergoes agonist- and antagonist-mediated internalization in the absence of signaling. Endocrinology. 1998; 139: 3185-92. (Pubitemid 28512348)
48. Roettger BF, Ghanekar D, Rao R, Toledo C, Yingling J, Pinon D, Miller LJ,. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol Pharmacol. 1997; 51: 357-62. (Pubitemid 27118469)
49. Bhattacharyya S, Puri S, Miledi R, Panicker MM,. Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms. Proc Natl Acad Sci USA. 2002; 99: 14470-5. (Pubitemid 35257695)
50. Bhattacharya S, Raote I, Bhattacharya A, Miledi R, Panicker MM,. Activation, internalization, and recycling of the serotonin 2A receptor by dopamine. Proc Natl Acad Sci USA. 2006; 103: 15248-53. (Pubitemid 44583196)
51. Raote I, Bhattacharya A, Panicker MM,. Serotonin 2A (5-HT2A) Receptor Function: Ligand-Dependent Mechanisms and Pathways. In:, Chattopadhyay A, editor. Serotonin Receptors in Neurobiology. 2011/01/05 ed., Boca Raton; 2007. pp 105-32.
52. Kurz JB, Perkins JP,. Isoproterenol-initiated ß-adrenergic receptor diacytosis in cultured cells. Mol Pharmacol. 1992; 41: 375-81.
53. von Zastrow M, Kobilka BK,. Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J Biol Chem. 1992; 267: 3530-8.
54. 2-adrenergic receptor internalization via the constitutive endocytic pathway into rab5-containing endosomes. J Cell Sci. 1995; 108 (Pt 9): 2983-91.
55. Tsao PI, von Zastrow M,. Type-specific sorting of G protein-coupled receptors after endocytosis. J Biol Chem. 2000; 275: 11130-40. (Pubitemid 30212756)
56. Klenk C, Schulz S, Calebiro D, Lohse MJ,. Agonist-regulated cleavage of the extracellular domain of parathyroid hormone receptor type 1. J Biol Chem. 2010; 285: 8665-74.
57. Abou-Samra AB, Goldsmith PK, Xie LY, Jüppner H, Spiegel AM, Segre GV,. Down-regulation of parathyroid (PTH)/PTH-related peptide receptor immunoreactivity and PTH binding in opossum kidney cells by PTH and dexamethasone. Endocrinology. 1994; 135: 2588-94. (Pubitemid 24377420)
58. Hicke L, Dunn R,. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu Rev Cell Dev Biol. 2003; 19: 141-72. (Pubitemid 37487346)
59. Li JG, Haines DS, Liu-Chen LY,. Agonist-promoted Lys63-linked polyubiquitination of the human kappa-opioid receptor is involved in receptor down-regulation. Mol Pharmacol. 2008; 73: 1319-30. (Pubitemid 351439214)
60. Murray EJ, Bentley GV, Grisanti MS, Murray SS,. The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells. Exp Cell Res. 1998; 242: 460-9. (Pubitemid 28359828)
61. Zhao L, Huang J, Guo R, Wang Y, Chen D, Xing L,. Smurf1 inhibits mesenchymal stem cell proliferation and differentiation into osteoblasts through JunB degradation. J Bone Miner Res. 2010; 25: 1246-56.
62. Yamashita M, Ying SX, Zhang GM, Li C, Cheng SY, Deng CX, Zhang YE,. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell. 2005; 121: 101-13.
63. Komander D, Clague MJ, Urbe S,. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009; 10: 550-63.
64. Milojevic T, Reiterer V, Stefan E, Korkhov VM, Dorostkar MM, Ducza E, Ogris E, Boehm S, Freissmuth M, Nanoff C,. The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol Pharmacol. 2006; 69: 1083-94.
65. Berlin I, Schwartz H, Nash PD,. Regulation of epidermal growth factor receptor ubiquitination and trafficking by the USP8.STAM complex. J Biol Chem. 2010; 285: 34909-21.
66. Berthouze M, Venkataramanan V, Li Y, Shenoy SK,. The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic receptor recycling and resensitization. EMBO J. 2009; 28: 1684-96.
67. Ferrandon S, Feinstein TN, Castro M, Wang B, Bouley R, Potts JT, Gardella TJ, Vilardaga JP,. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol. 2009; 5: 734-42.
68. Garrido JL, Wheeler D, Vega LL, Friedman PA, Romero G,. Role of phospholipase D in parathyroid hormone receptor type 1 signaling and trafficking. Mol Endocrinol. 2009; 23: 2048-59.
69. Feinstein TN, Wehbi VL, Ardura JA, Wheeler DS, Ferrandon S, Gardella TJ, Vilardaga JP,. Retromer terminates the generation of cAMP by internalized PTH receptors. Nat Chem Biol. 2011; 7: 278-84.
70. Llach F,. Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisited. Am J Kidney Dis. 1995; 25: 663-79.